Closing the implementation gap for hidradenitis suppurativa surgery and laser therapies in the NHS: comment on ‘The role of surgery in hidradenitis suppurativa: expert-based holistic approaches’
Abstract
Contemporary expert consensus recognizes surgery as a core modality in hidradenitis suppurativa (HS), yet UK NHS delivery remains misaligned with the evidence. Deroofing and laser therapy are underused because of commissioning variability, limited dermatological surgical capacity and fragmented multidisciplinary care, leading to delayed source control and preventable progression. Delays in biologic initiation and limited uptake of combined medical–surgical strategies further increase morbidity, despite evidence favouring integrated care. Commissioned minor surgical capacity, structured training, embedded laser pathways and coordinated HS services are needed to reduce avoidable late-stage intervention and patient burden.
Fields of Study & Subjects
Hidradenitis Suppurativa and Treatments
Autoimmune and Inflammatory Disorders
Actinomycetales infections and treatment
Publication details
- Journal / source
- Clinical and Experimental Dermatology
- Volume
- 51
- Issue
- 8
- Pages
- 1486–1487
- Publication date
- 28 February 2026
- Language
- EN